Advertisement

Research Article Free access | 10.1172/JCI109829

Elevated serum levels of pancreatic secretory proteins in cigarette smokers after secretin stimulation.

G Balldin, A Borgström, A Eddeland, S Genell, L Hagberg, and K Ohlsson

Find articles by Balldin, G. in: JCI | PubMed | Google Scholar

Find articles by Borgström, A. in: JCI | PubMed | Google Scholar

Find articles by Eddeland, A. in: JCI | PubMed | Google Scholar

Find articles by Genell, S. in: JCI | PubMed | Google Scholar

Find articles by Hagberg, L. in: JCI | PubMed | Google Scholar

Find articles by Ohlsson, K. in: JCI | PubMed | Google Scholar

Published July 1, 1980 - More info

Published in Volume 66, Issue 1 on July 1, 1980
J Clin Invest. 1980;66(1):159–162. https://doi.org/10.1172/JCI109829.
© 1980 The American Society for Clinical Investigation
Published July 1, 1980 - Version history
View PDF
Abstract

The secretory pancreatic proteins in serum were analyzed in a group of cigarette smokers and a control group of nonsmokers before and after intravenous secretin stimulation. None of these persons had any signs of pancreatic disease. In the control group, serum total amylase activity, pancreatic isoamylase, cationic trypsinogen, and pancreatic secretory trypsin inhibitor concentrations varied within the normal range before and after secretin injection. In contrast, the concentrations of these pancreatic proteins in all the cigarette smokers elevated from normal to abnormally high serum concentrations after secretin stimulation. The results indicate a probable toxic effect of cigarette smoking on the exocrine pancreas.

Browse pages

Click on an image below to see the page. View PDF of the complete article

Version history
  • Version 1 (July 1, 1980): No description
Advertisement
Advertisement